JavaScript is disabled for your browser. Some features of this site may not work without it.
Clinico-pathological Profiles and Treatment Responses of Patients on Brentuximab Vedotin Therapy for Cd30 Positive Relapsed/refractory Lymphomas Seen at the Nairobi Hospital Cancer Centre